Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Pregabalin 150 mg (Dexa Medica) vs Lyrica in Healthy Volunteers
NCT02233777Completed
- Sponsor
- Dexa Medica
- Start
- Jun 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pregabalin in neuropathic pain, epilepsy, generalized anxiety disorder (GAD) and 1 more (2 arms), sponsored by Dexa Medica. Primary endpoints: Area Under the Curve to the Last Measurable Concentration at 36 hours, Area Under the Curve to Infinity at 36 hours and 2 more. Started Jun 2014; status: completed.
02
Drugs
pregabalin
03
Conditions
neuropathic painepilepsygeneralized anxiety disorder (GAD)fibromyalgia (FM)
Beyond the preview
Go deeper on NCT02233777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233777.